Wesley supports the team by advising portfolio companies on business development and commercialization strategy. He is currently the CEO of LifeCycle Advisors, a firm supporting clients in commercial launch planning and deal diligence. He was formerly SVP of Business Operations at Global Blood Therapeutics supporting the launch of a novel Sickle Cell Disease Therapy. He served as VP of Commercial Operations, Market Access and Supply Chain for Hyperion Therapeutics, until their acquisition by Horizon Pharma. Prior to Hyperion, Wesley was the Head of Commercial Operations and Market Access at Belgium based ThromboGenics. He also held senior marketing, field and reimbursement roles for product launches at Amgen and Genentech. He has experience as a practice administrator in the Johns Hopkins Health System and as a reimbursement consultant at Andersen Consulting. Wesley holds a MHS in Health Policy from Johns Hopkins School of Public Health, an MBA from University of California Berkeley and a BS in Health Administration from University of Central Florida.